Category Archives: Limited Distribution Drugs

Onco360 Selected as Exclusive Specialty Pharmacy for Alexion Pharmaceutical’s Voydeya

Onco360 Selected as Exclusive Specialty Pharmacy to distribute Alexion Pharmaceutical’s Voydeya as a first class oral, Factor D inhibitor.

Specialty Pharmacy News Roundup: March 2024

The latest specialty pharmacy news and insights. Stay up to date on industry and company trends with Specialty Pharmacy Database and client-specific research.

Edenbridge Pharmaceuticals Selects Specialty Pharmacies to Distribute Yargesa

Edenbridge Pharmaceuticals Selects PANTHERx Rare and Orsini Specialty Pharmacy to Distribute Yargesa to Treat Gaucher Disease

BrightSpring Health Services Positioned For Growth in 2024

Pharmacy services provider BrightSpring Health Services (BrightSpring) is positioned for growth following its successful initial public offering (IPO) that was completed in January 2024

Specialty Pharmacy News Roundup: December 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

hATTR-PN Drug WAINUA™ Available at Orsini Specialty Pharmacy

WAINUA™ for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis is available at Orsini Specialty Pharmacy

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Biologics by McKesson and Onco360 Selected as Specialty Pharmacy Partners for Fruzaqla, Ogsiveo, and Truqap

Specialty Pharmacy News Roundup: November 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends